1D
-0.5%
0%
1W
5.82%
-0.51%
1M
-9.6%
2.17%
YTD
-30.14%
9.12%
1Y
-30.84%
4.28%
3Y
-37.4%
35.7%
5Y
21.21%
89.15%
10Y
0.38%
232.58%
- Stock Absolute Returns
- Absolute Returns
Total Returns (Price + Dividend) 
Dividend Yield (2.03%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.67%
1.69%
-14.98%
6 Months
-22.41%
1.55%
-20.86%
1 Year
-30.84%
1.39%
-29.45%
2 Years
-40.71%
2.33%
-38.38%
3 Years
-37.4%
3.52%
-33.88%
4 Years
-12.38%
5.95%
-6.43%
5 Years
21.21%
8.27%
29.48%
Latest dividend: 0.8 per share ex-dividend date: Sep-18-2025
What is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers 
Inconsistent Performance
Sandu Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods
3
Quartile
QTD
-13.81%
2
Quartile
Jun-Sep
-7.95%
3
Quartile
Mar-Jun
3.41%
2
Quartile
YTD
-30.5%
4
Quartile
2024
-15.92%
3
Quartile
2023
1.79%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry 
Underperformer
Sandu Pharmaceuticals Ltd has been in the Third and Fourth Quartile in the YTD and longer periods
3
Quartile
QTD
-13.81%
3
Quartile
Jun-Sep
-7.95%
3
Quartile
Mar-Jun
3.41%
3
Quartile
YTD
-30.5%
4
Quartile
2024
-15.92%
3
Quartile
2023
1.79%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap 
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available






